Mutations, mainly in TP53 and FBXW7, were observed in the adjacent non-dysplastic mucosa to PSC-IBD-CRCs, but the number of alterations was generally limited (zero to two per patient, with the exception of six mutations). The gene discussed is TP53; the disease is inflammatory bowel disease.